论文信息 - An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1 - 字舞流文

An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1

R. Strowd | K. Watabe | H. Lo | C. Furdui | T. Hollis | Sherona R. Sirkisoon | Dongqin Zhu | Noah R. Aguayo | Marlyn Anguelov | Sara G Manore | Daniel L Doheny | Mariana Najjar | Alexandria Harrison | Anderson O’Brien Cox | Alexandra Thomas | Sara G. Manore | Mariana K. Najjar | Mariana K Najjar | N. Aguayo | A. O. Cox